Show simple item record

dc.contributor.authorvan Sluijs, L
dc.contributor.authorvan Houte, S
dc.contributor.authorvan der Oost, J
dc.contributor.authorBrouns, SJJ
dc.contributor.authorBuckling, A
dc.contributor.authorWestra, ER
dc.date.accessioned2019-04-08T10:46:31Z
dc.date.issued2019-03-05
dc.description.abstractCRISPR-Cas systems provide adaptive immunity against mobile genetic elements, but employment of this resistance mechanism is often reported with a fitness cost for the host. Whether or not CRISPR-Cas systems are important barriers for the horizontal spread of conjugative plasmids, which play a crucial role in the spread of antibiotic resistance, will depend on the fitness costs of employing CRISPR-based defences and the benefits of resisting conjugative plasmids. To estimate these costs and benefits we measured bacterial fitness associated with plasmid immunity using Escherichia coli and the conjugative plasmid pOX38-Cm. We find that CRISPR-mediated immunity fails to confer a fitness benefit in the absence of antibiotics, despite the large fitness cost associated with carrying the plasmid in this context. Similar to many other conjugative plasmids, pOX38-Cm carries a CcdAB toxin-antitoxin (TA) addiction system. These addiction systems encode long-lived toxins and short-lived anti-toxins, resulting in toxic effects following the loss of the TA genes from the bacterial host. Our data suggest that the lack of a fitness benefit associated with CRISPR-mediated defence is due to expression of the TA system before plasmid detection and degradation. As most antibiotic resistance plasmids encode TA systems this could have important consequences for the role of CRISPR-Cas systems in limiting the spread of antibiotic resistance.en_GB
dc.description.sponsorshipEuropean Commissionen_GB
dc.description.sponsorshipBiotechnology & Biological Sciences Research Council (BBSRC)en_GB
dc.description.sponsorshipNatural Environment Research Councilen_GB
dc.description.sponsorshipRoyal Society of Biological Sciencesen_GB
dc.description.sponsorshipNetherlands Organization of Scientific Research (NWO)en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.identifier.citationPublished online 5 March 2019en_GB
dc.identifier.doi10.1093/femsle/fnz047
dc.identifier.grantnumber752979en_GB
dc.identifier.grantnumberBB/R010781/1en_GB
dc.identifier.grantnumberNWO-TOP,854.10.003en_GB
dc.identifier.grantnumberNWO Vidi, 864.11.005en_GB
dc.identifier.grantnumberFP7/2007-2013en_GB
dc.identifier.grantnumber327606en_GB
dc.identifier.grantnumberERC-STG-2016-714478 - EVOIMMECHen_GB
dc.identifier.grantnumberBB/N017412/1en_GB
dc.identifier.grantnumber109776/Z/15/Zen_GB
dc.identifier.grantnumberNE/M018350/1en_GB
dc.identifier.other5369624
dc.identifier.urihttp://hdl.handle.net/10871/36762
dc.language.isoenen_GB
dc.publisherOxford University Press (OUP)en_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/30834930en_GB
dc.rights© FEMS 2019. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectCRISPRen_GB
dc.subjectTAen_GB
dc.subjectadaptive immunityen_GB
dc.subjectbacteriaen_GB
dc.subjectplasmiden_GB
dc.subjecttoxinen_GB
dc.titleAddiction systems antagonize bacterial adaptive immunity.en_GB
dc.typeArticleen_GB
dc.date.available2019-04-08T10:46:31Z
exeter.place-of-publicationEnglanden_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from Oxford University Press (OUP) via the DOI in this record. en_GB
dc.identifier.journalFEMS Microbiology Lettersen_GB
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2019-03-05
exeter.funder::European Commissionen_GB
exeter.funder::Biotechnology & Biological Sciences Research Council (BBSRC)en_GB
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2019-03-05
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-04-08T10:38:16Z
refterms.versionFCDAM
refterms.dateFOA2019-04-08T10:46:33Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© FEMS 2019. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's licence is described as © FEMS 2019. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.